跳到正文
原文
Moderna· @moderna_tx · X·· 5 天前AI 评分22
AI 导读

今天,我们在2026年分析师日上阐述了下一阶段的增长规划,重点介绍了十余年来对mRNA平台的投资如何推动了多种mRNA药物模式的开发,每一种模式都有潜力打造持久的业务版图。 我们还介绍了商业化增长、肿瘤管线进展、生产准备情况以及中期财务目标的最新信息。 阅读更多:https://feeds.issuerdirect.com/news-release.html?newsid=8697104470082996&symbol=MRNA

正文

Today we outlined the next phase of growth at our 2026 Analyst Day, highlighting how more than a decade of investment in our mRNA platform has enabled the development of multiple modalities of mRNA medicines, each with the potential to create durable franchises.

We also provided updates on commercial growth, oncology pipeline progress, manufacturing readiness and mid-term financial objectives.

Read more: https://feeds.issuerdirect.com/news-release.html?newsid=8697104470082996&symbol=MRNA

来源:Moderna · x.com